Subscribe To
ABSI / Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
ABSI News
By GlobeNewsWire
August 28, 2023
Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announ more_horizontal
By InvestorPlace
August 14, 2023
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
Penny stocks are often defined as stocks trading under $5 per share, those with a very low price per share or market capitalization, and are generally more_horizontal
By Zacks Investment Research
May 15, 2023
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Absci Corporation (ABSI) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to lo more_horizontal
By Forbes
February 28, 2023
Absci Takes Its Generative AI Antibody Design Platform To Europe
Generative AI technology, like ChatGPT, is disrupting many industries including biopharma. For example, Absci is using AI to design & validate de novo more_horizontal
By Benzinga
March 23, 2022
Here's Why Absci Corp Shares Are Falling
Absci Corp (NASDAQ: ABSI) shares are trading lower by 9.2% at $6.79 after the company reported fourth-quarter earnings results. Absci reported quarte more_horizontal